Share Price and Basic Stock Data
Last Updated: December 12, 2025, 4:56 pm
| PEG Ratio | 5.19 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Infosys Ltd, one of India’s leading IT consulting and software firms, reported a robust revenue of ₹146,767 Cr for the fiscal year ending March 2023, showcasing a consistent upward trajectory from ₹121,641 Cr in the previous fiscal year. This growth trajectory reflects Infosys’s strong position in the IT services sector, particularly in digital transformation projects, which are increasingly in demand across various industries. The company’s quarterly sales figures also illustrate resilience, with a slight dip in the March 2023 quarter at ₹37,441 Cr, followed by a recovery to ₹38,994 Cr by September 2023. Such fluctuations are not uncommon in the IT sector, especially given the seasonal nature of project cycles. However, the overall trend remains positive, with expected sales for March 2025 projected at ₹162,990 Cr, indicating a healthy compound annual growth rate. This consistent revenue growth positions Infosys well among its peers, even as the global economic landscape evolves.
Profitability and Efficiency Metrics
In terms of profitability, Infosys’s operating profit margin (OPM) stood at a commendable 24% for the fiscal year ending March 2025. This margin has remained stable over recent years, reflecting the company’s efficient cost management and operational capabilities. The net profit for the same period was reported at ₹26,750 Cr, which highlights the company’s ability to convert revenue into profit effectively. Moreover, the return on equity (ROE) of 27.87% and return on capital employed (ROCE) of 35.85% are indicators of strong profitability relative to shareholder equity and capital used, respectively. However, the OPM has shown a slight decline from previous years, which could signal increasing competitive pressures or rising operational costs. The interest coverage ratio, at an impressive 102.97x, showcases the company’s ability to meet its financial obligations comfortably, further solidifying its financial health.
Balance Sheet Strength and Financial Ratios
Infosys’s balance sheet reflects a solid foundation, with total assets recorded at ₹147,795 Cr and total liabilities at ₹160,380 Cr as of March 2025. The firm has substantial reserves amounting to ₹101,256 Cr, which provides a cushion against economic uncertainties and facilitates future investments. Despite having borrowings of ₹8,755 Cr, the company’s debt levels appear manageable, especially given its strong cash flow generation capabilities. The price-to-book value (P/BV) ratio of 6.79x indicates that the market is valuing Infosys at a premium compared to its book value, which can be interpreted as a reflection of investor confidence in the company’s growth potential. However, the current ratio of 2.27x suggests that Infosys maintains a comfortable liquidity position, essential for navigating any short-term financial challenges. These financial ratios collectively depict a company that is not only profitable but also well-positioned to sustain growth and manage risks effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Infosys reveals a diverse ownership structure that includes 14.30% held by promoters, 30.08% by foreign institutional investors (FIIs), and a significant 41.46% held by domestic institutional investors (DIIs). This distribution indicates strong institutional confidence in the company, which is often viewed positively by retail investors. The gradual decline in promoter holdings, from 15.14% in March 2023 to 14.30% in September 2025, could raise questions about insider confidence; however, the steady institutional support suggests that these entities continue to see value in Infosys. The total number of shareholders has also seen a healthy increase, reaching over 27 lakh, which underscores growing retail interest and participation in the stock. This broad base of support can provide stability to the stock price, particularly in volatile market conditions.
Outlook, Risks, and Final Insight
Looking ahead, Infosys appears well-positioned to capitalize on the growing demand for digital transformation services and cloud solutions, which are critical for businesses adapting to a post-pandemic landscape. However, potential risks loom, including increasing competition from both domestic and global players, which may pressure margins. Additionally, the company must navigate geopolitical tensions and macroeconomic uncertainties that could impact client spending. While the fundamentals remain strong, investors should consider these factors when evaluating the stock. Balancing growth potential against these risks will be crucial. For investors, the journey with Infosys seems promising, but it requires a keen eye on market dynamics and company performance metrics to make informed decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.38 Cr. | 225 | 225/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 12.5 Cr. | 21.2 | 21.2/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 112 Cr. | 69.2 | 101/17.6 | 55.1 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 11.8 Cr. | 40.8 | 64.9/33.1 | 8.00 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 25.8 Cr. | 75.0 | 200/67.0 | 17.5 | 15.0 | 1.33 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 123,231.56 Cr | 818.64 | 47.04 | 158.22 | 0.77% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34,470 | 36,538 | 38,318 | 37,441 | 37,933 | 38,994 | 38,821 | 37,923 | 39,315 | 40,986 | 41,764 | 40,925 | 42,279 |
| Expenses | 26,606 | 27,636 | 28,951 | 28,443 | 28,869 | 29,554 | 29,684 | 29,139 | 29,878 | 31,177 | 31,649 | 31,051 | 32,336 |
| Operating Profit | 7,864 | 8,902 | 9,367 | 8,998 | 9,064 | 9,440 | 9,137 | 8,784 | 9,437 | 9,809 | 10,115 | 9,874 | 9,943 |
| OPM % | 23% | 24% | 24% | 24% | 24% | 24% | 24% | 23% | 24% | 24% | 24% | 24% | 24% |
| Other Income | 676 | 584 | 769 | 671 | 561 | 632 | 789 | 2,729 | 838 | 712 | 859 | 1,190 | 1,042 |
| Interest | 56 | 66 | 80 | 82 | 90 | 138 | 131 | 110 | 105 | 108 | 101 | 102 | 105 |
| Depreciation | 950 | 1,029 | 1,125 | 1,121 | 1,173 | 1,166 | 1,176 | 1,163 | 1,149 | 1,160 | 1,203 | 1,299 | 1,140 |
| Profit before tax | 7,534 | 8,391 | 8,931 | 8,466 | 8,362 | 8,768 | 8,619 | 10,240 | 9,021 | 9,253 | 9,670 | 9,663 | 9,740 |
| Tax % | 29% | 28% | 26% | 28% | 29% | 29% | 29% | 22% | 29% | 30% | 29% | 27% | 29% |
| Net Profit | 5,362 | 6,026 | 6,586 | 6,134 | 5,945 | 6,215 | 6,113 | 7,975 | 6,374 | 6,516 | 6,822 | 7,038 | 6,924 |
| EPS in Rs | 12.74 | 14.31 | 15.70 | 14.77 | 14.32 | 14.97 | 14.71 | 19.20 | 15.34 | 15.67 | 16.39 | 16.93 | 16.66 |
Last Updated: August 2, 2025, 1:10 am
Below is a detailed analysis of the quarterly data for Infosys Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 42,279.00 Cr.. The value appears strong and on an upward trend. It has increased from 40,925.00 Cr. (Mar 2025) to 42,279.00 Cr., marking an increase of 1,354.00 Cr..
- For Expenses, as of Jun 2025, the value is 32,336.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31,051.00 Cr. (Mar 2025) to 32,336.00 Cr., marking an increase of 1,285.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 9,943.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,874.00 Cr. (Mar 2025) to 9,943.00 Cr., marking an increase of 69.00 Cr..
- For OPM %, as of Jun 2025, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.00%.
- For Other Income, as of Jun 2025, the value is 1,042.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,190.00 Cr. (Mar 2025) to 1,042.00 Cr., marking a decrease of 148.00 Cr..
- For Interest, as of Jun 2025, the value is 105.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 1,140.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,299.00 Cr. (Mar 2025) to 1,140.00 Cr., marking a decrease of 159.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 9,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,663.00 Cr. (Mar 2025) to 9,740.00 Cr., marking an increase of 77.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Mar 2025) to 29.00%, marking an increase of 2.00%.
- For Net Profit, as of Jun 2025, the value is 6,924.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,038.00 Cr. (Mar 2025) to 6,924.00 Cr., marking a decrease of 114.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.66. The value appears to be declining and may need further review. It has decreased from 16.93 (Mar 2025) to 16.66, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 4:16 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 50,133 | 53,319 | 62,441 | 68,484 | 70,522 | 82,675 | 90,791 | 100,472 | 121,641 | 146,767 | 153,670 | 162,990 | 165,954 |
| Expenses | 36,743 | 38,436 | 45,362 | 49,880 | 51,700 | 62,505 | 68,524 | 72,583 | 90,150 | 111,637 | 117,245 | 123,754 | 126,213 |
| Operating Profit | 13,390 | 14,883 | 17,079 | 18,604 | 18,822 | 20,170 | 22,267 | 27,889 | 31,491 | 35,130 | 36,425 | 39,236 | 39,741 |
| OPM % | 27% | 28% | 27% | 27% | 27% | 24% | 25% | 28% | 26% | 24% | 24% | 24% | 24% |
| Other Income | 2,664 | 3,430 | 3,120 | 3,050 | 3,311 | 2,882 | 2,803 | 2,201 | 2,295 | 2,701 | 4,711 | 3,600 | 3,803 |
| Interest | 9 | 12 | 0 | 0 | 0 | 0 | 170 | 195 | 200 | 284 | 470 | 416 | 416 |
| Depreciation | 1,317 | 1,017 | 1,459 | 1,703 | 1,863 | 2,011 | 2,893 | 3,267 | 3,476 | 4,225 | 4,678 | 4,812 | 4,802 |
| Profit before tax | 14,728 | 17,284 | 18,740 | 19,951 | 20,270 | 21,041 | 22,007 | 26,628 | 30,110 | 33,322 | 35,988 | 37,608 | 38,326 |
| Tax % | 28% | 28% | 28% | 28% | 21% | 27% | 24% | 27% | 26% | 28% | 27% | 29% | |
| Net Profit | 10,656 | 12,372 | 13,489 | 14,353 | 16,029 | 15,410 | 16,639 | 19,423 | 22,146 | 24,108 | 26,248 | 26,750 | 27,300 |
| EPS in Rs | 23.31 | 26.93 | 29.36 | 31.24 | 36.69 | 35.26 | 38.96 | 45.42 | 52.56 | 58.08 | 63.20 | 64.32 | 65.65 |
| Dividend Payout % | 34% | 55% | 41% | 41% | 59% | 60% | 45% | 59% | 59% | 58% | 73% | 67% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.10% | 9.03% | 6.41% | 11.68% | -3.86% | 7.98% | 16.73% | 14.02% | 8.86% | 8.88% | 1.91% |
| Change in YoY Net Profit Growth (%) | 0.00% | -7.08% | -2.62% | 5.27% | -15.54% | 11.84% | 8.76% | -2.71% | -5.16% | 0.02% | -6.96% |
Infosys Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 0% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 30% |
| 3 Years: | 31% |
| Last Year: | 29% |
Last Updated: September 4, 2025, 9:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:52 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 286 | 572 | 1,144 | 1,144 | 1,088 | 2,170 | 2,122 | 2,124 | 2,098 | 2,069 | 2,071 | 2,073 | 2,074 |
| Reserves | 44,244 | 50,164 | 60,600 | 67,838 | 63,835 | 62,778 | 63,328 | 74,227 | 73,252 | 73,338 | 86,045 | 93,745 | 101,256 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 4,633 | 5,325 | 5,474 | 8,299 | 8,359 | 8,227 | 8,755 |
| Other Liabilities | 12,436 | 15,553 | 13,354 | 14,166 | 14,426 | 19,118 | 21,717 | 25,835 | 35,905 | 40,890 | 40,885 | 43,750 | 48,295 |
| Total Liabilities | 56,966 | 66,289 | 75,098 | 83,148 | 79,349 | 84,066 | 91,800 | 107,511 | 116,729 | 124,596 | 137,360 | 147,795 | 160,380 |
| Fixed Assets | 8,378 | 11,346 | 13,386 | 14,179 | 12,574 | 15,710 | 23,789 | 25,505 | 25,800 | 29,225 | 27,622 | 30,961 | 32,656 |
| CWIP | 961 | 776 | 960 | 1,365 | 1,606 | 1,388 | 954 | 922 | 416 | 288 | 293 | 814 | 1,124 |
| Investments | 4,331 | 2,270 | 1,892 | 16,423 | 12,163 | 11,261 | 8,792 | 14,205 | 20,324 | 19,478 | 24,623 | 23,541 | 23,485 |
| Other Assets | 43,296 | 51,897 | 58,860 | 51,181 | 53,006 | 55,707 | 58,265 | 66,879 | 70,189 | 75,605 | 84,822 | 92,479 | 103,115 |
| Total Assets | 56,966 | 66,289 | 75,098 | 83,148 | 79,349 | 84,066 | 91,800 | 107,511 | 116,729 | 124,596 | 137,360 | 147,795 | 160,380 |
Below is a detailed analysis of the balance sheet data for Infosys Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 2,074.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,073.00 Cr. (Mar 2025) to 2,074.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Sep 2025, the value is 101,256.00 Cr.. The value appears strong and on an upward trend. It has increased from 93,745.00 Cr. (Mar 2025) to 101,256.00 Cr., marking an increase of 7,511.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8,755.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 8,227.00 Cr. (Mar 2025) to 8,755.00 Cr., marking an increase of 528.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 48,295.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43,750.00 Cr. (Mar 2025) to 48,295.00 Cr., marking an increase of 4,545.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 160,380.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 147,795.00 Cr. (Mar 2025) to 160,380.00 Cr., marking an increase of 12,585.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 32,656.00 Cr.. The value appears strong and on an upward trend. It has increased from 30,961.00 Cr. (Mar 2025) to 32,656.00 Cr., marking an increase of 1,695.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,124.00 Cr.. The value appears strong and on an upward trend. It has increased from 814.00 Cr. (Mar 2025) to 1,124.00 Cr., marking an increase of 310.00 Cr..
- For Investments, as of Sep 2025, the value is 23,485.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23,541.00 Cr. (Mar 2025) to 23,485.00 Cr., marking a decrease of 56.00 Cr..
- For Other Assets, as of Sep 2025, the value is 103,115.00 Cr.. The value appears strong and on an upward trend. It has increased from 92,479.00 Cr. (Mar 2025) to 103,115.00 Cr., marking an increase of 10,636.00 Cr..
- For Total Assets, as of Sep 2025, the value is 160,380.00 Cr.. The value appears strong and on an upward trend. It has increased from 147,795.00 Cr. (Mar 2025) to 160,380.00 Cr., marking an increase of 12,585.00 Cr..
Notably, the Reserves (101,256.00 Cr.) exceed the Borrowings (8,755.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 13.00 | 14.00 | 17.00 | 18.00 | 18.00 | 20.00 | 18.00 | 22.00 | 26.00 | 27.00 | 28.00 | 31.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 66 | 66 | 66 | 68 | 65 | 74 | 70 | 68 | 63 | 72 | 70 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 61 | 66 | 66 | 66 | 68 | 65 | 74 | 70 | 68 | 63 | 72 | 70 |
| Working Capital Days | 15 | 3 | 34 | 38 | 50 | 36 | 42 | 36 | 28 | 31 | 54 | 39 |
| ROCE % | 36% | 36% | 33% | 30% | 30% | 32% | 32% | 35% | 37% | 40% | 40% | 38% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Value Fund | 28,381,728 | 7.26 | 4207.02 | N/A | N/A | N/A |
| ICICI Prudential Technology Fund | 20,849,081 | 20.24 | 3090.46 | 17,580,044 | 2025-12-08 06:30:49 | 18.6% |
| ICICI Prudential Large Cap Fund | 18,055,818 | 3.53 | 2676.41 | N/A | N/A | N/A |
| HDFC Balanced Advantage Fund | 16,763,803 | 2.33 | 2484.9 | N/A | N/A | N/A |
| Mirae Asset Large Cap Fund | 15,003,321 | 5.41 | 2223.94 | 13,973,661 | 2025-12-08 06:30:49 | 7.37% |
| ICICI Prudential India Opportunities Fund | 14,979,251 | 6.8 | 2220.37 | N/A | N/A | N/A |
| ICICI Prudential Balanced Advantage Fund | 14,781,028 | 3.2 | 2190.99 | N/A | N/A | N/A |
| Tata Digital India Fund | 14,647,773 | 18.41 | 2171.24 | N/A | N/A | N/A |
| SBI Large Cap Fund | 14,600,000 | 3.96 | 2164.16 | N/A | N/A | N/A |
| SBI Equity Hybrid Fund | 13,000,000 | 2.35 | 1926.99 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 64.50 | 63.39 | 57.63 | 52.52 | 45.61 |
| Diluted EPS (Rs.) | 64.34 | 63.39 | 57.54 | 52.41 | 45.52 |
| Cash EPS (Rs.) | 76.13 | 74.66 | 68.47 | 61.06 | 53.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 231.11 | 212.74 | 183.17 | 180.50 | 180.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 231.11 | 212.74 | 183.17 | 180.50 | 180.75 |
| Revenue From Operations / Share (Rs.) | 393.13 | 371.00 | 354.68 | 289.90 | 236.52 |
| PBDIT / Share (Rs.) | 103.32 | 99.31 | 91.42 | 80.52 | 70.83 |
| PBIT / Share (Rs.) | 91.71 | 88.02 | 81.21 | 72.23 | 63.14 |
| PBT / Share (Rs.) | 90.71 | 86.89 | 80.53 | 71.76 | 62.68 |
| Net Profit / Share (Rs.) | 64.52 | 63.37 | 58.26 | 52.78 | 45.72 |
| NP After MI And SOA / Share (Rs.) | 64.43 | 63.33 | 58.23 | 52.69 | 45.55 |
| PBDIT Margin (%) | 26.28 | 26.76 | 25.77 | 27.77 | 29.94 |
| PBIT Margin (%) | 23.32 | 23.72 | 22.89 | 24.91 | 26.69 |
| PBT Margin (%) | 23.07 | 23.41 | 22.70 | 24.75 | 26.50 |
| Net Profit Margin (%) | 16.41 | 17.08 | 16.42 | 18.20 | 19.33 |
| NP After MI And SOA Margin (%) | 16.38 | 17.07 | 16.41 | 18.17 | 19.26 |
| Return on Networth / Equity (%) | 27.87 | 29.77 | 31.95 | 29.34 | 25.34 |
| Return on Capital Employeed (%) | 35.85 | 36.81 | 38.79 | 35.96 | 31.73 |
| Return On Assets (%) | 17.93 | 19.03 | 19.15 | 18.75 | 17.85 |
| Asset Turnover Ratio (%) | 1.14 | 1.17 | 1.20 | 1.08 | 0.92 |
| Current Ratio (X) | 2.27 | 2.31 | 1.81 | 2.00 | 2.54 |
| Quick Ratio (X) | 2.27 | 2.31 | 1.81 | 2.00 | 2.54 |
| Dividend Payout Ratio (NP) (%) | 75.97 | 56.00 | 56.57 | 57.23 | 47.12 |
| Dividend Payout Ratio (CP) (%) | 64.37 | 47.53 | 48.13 | 49.46 | 40.32 |
| Earning Retention Ratio (%) | 24.03 | 44.00 | 43.43 | 42.77 | 52.88 |
| Cash Earning Retention Ratio (%) | 35.63 | 52.47 | 51.87 | 50.54 | 59.68 |
| Interest Coverage Ratio (X) | 102.97 | 87.52 | 133.21 | 168.93 | 154.31 |
| Interest Coverage Ratio (Post Tax) (X) | 65.30 | 56.85 | 85.89 | 111.73 | 100.61 |
| Enterprise Value (Cr.) | 627017.84 | 606361.96 | 578997.26 | 783175.12 | 556737.20 |
| EV / Net Operating Revenue (X) | 3.85 | 3.95 | 3.94 | 6.44 | 5.54 |
| EV / EBITDA (X) | 14.64 | 14.74 | 15.30 | 23.18 | 18.50 |
| MarketCap / Net Operating Revenue (X) | 3.99 | 4.04 | 4.03 | 6.58 | 5.78 |
| Retention Ratios (%) | 24.02 | 43.99 | 43.42 | 42.76 | 52.87 |
| Price / BV (X) | 6.79 | 7.05 | 7.83 | 10.62 | 7.61 |
| Price / Net Operating Revenue (X) | 3.99 | 4.04 | 4.03 | 6.58 | 5.78 |
| EarningsYield | 0.04 | 0.04 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Infosys Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 64.50. This value is within the healthy range. It has increased from 63.39 (Mar 24) to 64.50, marking an increase of 1.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is 64.34. This value is within the healthy range. It has increased from 63.39 (Mar 24) to 64.34, marking an increase of 0.95.
- For Cash EPS (Rs.), as of Mar 25, the value is 76.13. This value is within the healthy range. It has increased from 74.66 (Mar 24) to 76.13, marking an increase of 1.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.11. It has increased from 212.74 (Mar 24) to 231.11, marking an increase of 18.37.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.11. It has increased from 212.74 (Mar 24) to 231.11, marking an increase of 18.37.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 393.13. It has increased from 371.00 (Mar 24) to 393.13, marking an increase of 22.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 103.32. This value is within the healthy range. It has increased from 99.31 (Mar 24) to 103.32, marking an increase of 4.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.71. This value is within the healthy range. It has increased from 88.02 (Mar 24) to 91.71, marking an increase of 3.69.
- For PBT / Share (Rs.), as of Mar 25, the value is 90.71. This value is within the healthy range. It has increased from 86.89 (Mar 24) to 90.71, marking an increase of 3.82.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 64.52. This value is within the healthy range. It has increased from 63.37 (Mar 24) to 64.52, marking an increase of 1.15.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 64.43. This value is within the healthy range. It has increased from 63.33 (Mar 24) to 64.43, marking an increase of 1.10.
- For PBDIT Margin (%), as of Mar 25, the value is 26.28. This value is within the healthy range. It has decreased from 26.76 (Mar 24) to 26.28, marking a decrease of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 23.32. This value exceeds the healthy maximum of 20. It has decreased from 23.72 (Mar 24) to 23.32, marking a decrease of 0.40.
- For PBT Margin (%), as of Mar 25, the value is 23.07. This value is within the healthy range. It has decreased from 23.41 (Mar 24) to 23.07, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is 16.41. This value exceeds the healthy maximum of 10. It has decreased from 17.08 (Mar 24) to 16.41, marking a decrease of 0.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.38. This value is within the healthy range. It has decreased from 17.07 (Mar 24) to 16.38, marking a decrease of 0.69.
- For Return on Networth / Equity (%), as of Mar 25, the value is 27.87. This value is within the healthy range. It has decreased from 29.77 (Mar 24) to 27.87, marking a decrease of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 35.85. This value is within the healthy range. It has decreased from 36.81 (Mar 24) to 35.85, marking a decrease of 0.96.
- For Return On Assets (%), as of Mar 25, the value is 17.93. This value is within the healthy range. It has decreased from 19.03 (Mar 24) to 17.93, marking a decrease of 1.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.17 (Mar 24) to 1.14, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 2.27, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 2.27. This value exceeds the healthy maximum of 2. It has decreased from 2.31 (Mar 24) to 2.27, marking a decrease of 0.04.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.97. This value exceeds the healthy maximum of 50. It has increased from 56.00 (Mar 24) to 75.97, marking an increase of 19.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 64.37. This value exceeds the healthy maximum of 50. It has increased from 47.53 (Mar 24) to 64.37, marking an increase of 16.84.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.03. This value is below the healthy minimum of 40. It has decreased from 44.00 (Mar 24) to 24.03, marking a decrease of 19.97.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 35.63. This value is below the healthy minimum of 40. It has decreased from 52.47 (Mar 24) to 35.63, marking a decrease of 16.84.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 102.97. This value is within the healthy range. It has increased from 87.52 (Mar 24) to 102.97, marking an increase of 15.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 65.30. This value is within the healthy range. It has increased from 56.85 (Mar 24) to 65.30, marking an increase of 8.45.
- For Enterprise Value (Cr.), as of Mar 25, the value is 627,017.84. It has increased from 606,361.96 (Mar 24) to 627,017.84, marking an increase of 20,655.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.85. This value exceeds the healthy maximum of 3. It has decreased from 3.95 (Mar 24) to 3.85, marking a decrease of 0.10.
- For EV / EBITDA (X), as of Mar 25, the value is 14.64. This value is within the healthy range. It has decreased from 14.74 (Mar 24) to 14.64, marking a decrease of 0.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.99. This value exceeds the healthy maximum of 3. It has decreased from 4.04 (Mar 24) to 3.99, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 24.02. This value is below the healthy minimum of 30. It has decreased from 43.99 (Mar 24) to 24.02, marking a decrease of 19.97.
- For Price / BV (X), as of Mar 25, the value is 6.79. This value exceeds the healthy maximum of 3. It has decreased from 7.05 (Mar 24) to 6.79, marking a decrease of 0.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.99. This value exceeds the healthy maximum of 3. It has decreased from 4.04 (Mar 24) to 3.99, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Infosys Ltd:
- Net Profit Margin: 16.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 35.85% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 27.87% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 65.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.6 (Industry average Stock P/E: 47.04)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | No. 44, Hosur Road, Electronics City, Bengaluru Karnataka 560100 | investors@infosys.com http://www.infosys.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nandan M Nilekani | Chairman (Non - Executive) & Non Independent Direc |
| Mr. Salil Parekh | Managing Director & CEO |
| Mr. D Sundaram | Lead Independent Director |
| Mr. Michael Gibbs | Independent Director |
| Mr. Govind Iyer | Independent Director |
| Ms. Chitra Nayak | Independent Director |
| Mr. Bobby Parikh | Independent Director |
| Ms. Helene Auriol Potier | Independent Director |
| Mr. Nitin Paranjpe | Independent Director |
FAQ
What is the intrinsic value of Infosys Ltd?
Infosys Ltd's intrinsic value (as of 12 December 2025) is 1390.34 which is 13.05% lower the current market price of 1,599.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,64,304 Cr. market cap, FY2025-2026 high/low of 2,007/1,307, reserves of ₹101,256 Cr, and liabilities of 160,380 Cr.
What is the Market Cap of Infosys Ltd?
The Market Cap of Infosys Ltd is 6,64,304 Cr..
What is the current Stock Price of Infosys Ltd as on 12 December 2025?
The current stock price of Infosys Ltd as on 12 December 2025 is 1,599.
What is the High / Low of Infosys Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Infosys Ltd stocks is 2,007/1,307.
What is the Stock P/E of Infosys Ltd?
The Stock P/E of Infosys Ltd is 23.6.
What is the Book Value of Infosys Ltd?
The Book Value of Infosys Ltd is 249.
What is the Dividend Yield of Infosys Ltd?
The Dividend Yield of Infosys Ltd is 2.69 %.
What is the ROCE of Infosys Ltd?
The ROCE of Infosys Ltd is 37.5 %.
What is the ROE of Infosys Ltd?
The ROE of Infosys Ltd is 28.8 %.
What is the Face Value of Infosys Ltd?
The Face Value of Infosys Ltd is 5.00.